VeriMombombyx mori extract hamilelikte güvenli mi?
No harmonised CLP classification for reproductive toxicity (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive concerns. Peer‑reviewed literature does not identify developmental or reproductive toxicity for Bombyx mori extract used in cosmetics; ingredient is a high‑molecular‑weight proteinaceous extract with low likelihood of systemic absorption from topical use (sources: ECHA Annex VI absence of harmonised classification; PubChem/CosIng listings; PubMed search yields no reproductive hazard reports).
Related ingredients
Frequently asked questions
- bombyx mori extract hamilelikte güvenli mi?
- No harmonised CLP classification for reproductive toxicity (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive concerns. Peer‑reviewed literature does not identify developmental or reproductive toxicity for Bombyx mori extract used in cosmetics; ingredient is a high‑molecular‑weight proteinaceous extract with low likelihood of systemic absorption from topical use (sources: ECHA Annex VI absence of harmonised classification; PubChem/CosIng listings; PubMed search yields no reproductive hazard reports).
- bombyx mori extract emzirirken güvenli mi?
- No data or regulatory flags for reproductive or lactation hazards. Given topical cosmetic use and the proteinaceous nature of the extract (large molecules), systemic bioavailability is expected to be negligible so transfer into breast milk is unlikely; no studies indicate risk to nursing infants (sources: PubChem, CosIng, PubMed).
- bombyx mori extract bebek cildi için güvenli mi?
- No evidence of developmental or infant‑specific toxicity. Bombyx mori extract is primarily protein/peptide material (low skin penetration expected); therefore exposure to infants via topical cosmetic use is expected to be low and no infant‑specific hazards were identified in available literature or regulatory listings. Note: potential for topical allergic contact reactions exists for proteinaceous ingredients, but no data indicate systemic or developmental risk (sources: PubMed, EWG, CosIng).
- VeriMom bombyx mori extract nasıl puanlıyor?
- VeriMom bombyx mori extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte bombyx mori extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.